lobbying_activities: 838737

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
838737	f798747a-832d-48a7-8496-f73df534d49d	Q3	THE OB-C GROUP, LLC	29802	ELI LILLY	2009	third_quarter	PHA	HR 1548, Pathway for Biosimilars Act: entire bill. No specific bill number: matters relating to pharmaceutical manufacturers in Health Care Reform.	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2009-10-19T14:59:33-04:00